256 related articles for article (PubMed ID: 8968650)
21. [Therapeutic treatment with neuroleptics. II: Subjective mechanisms of effect, compliance and consequences for treatment strategy].
Krausz M; Sorgenfrei T
Psychiatr Prax; 1991 Jan; 18(1):14-20. PubMed ID: 1674155
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic principles for differential therapy of psychoses].
Hell D; Bridler R
Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
[TBL] [Abstract][Full Text] [Related]
23. First-episode schizophrenia: the importance of early intervention and subjective tolerability.
Kasper S
J Clin Psychiatry; 1999; 60 Suppl 23():5-9. PubMed ID: 10625193
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of schizophrenia from the viewpoint of the patient. Studies on the course of treatment and neuroleptic treatment from a personal perspective].
Windgassen K
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1989; 58():1-169. PubMed ID: 2576099
[No Abstract] [Full Text] [Related]
25. The evolving definition of treatment resistance.
Peuskens J
J Clin Psychiatry; 1999; 60 Suppl 12():4-8. PubMed ID: 10372602
[TBL] [Abstract][Full Text] [Related]
26. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
Hornung WP; Schonauer K; Feldmann R; Mönking HS
Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
[TBL] [Abstract][Full Text] [Related]
27. Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).
Grunze HC; Höschl C; Montgomery SA; Sartorius N; Vieta E
J Clin Psychopharmacol; 2009 Aug; 29(4):409; author reply 409-10. PubMed ID: 19593194
[No Abstract] [Full Text] [Related]
28. A prototype approach toward antipsychotic medication adherence in schizophrenia.
Freudenreich O; Tranulis C
Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
[TBL] [Abstract][Full Text] [Related]
29. [The (new) definition of compliance].
Arolt V
Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
[No Abstract] [Full Text] [Related]
30. Evaluating clinical trial data: outcome measures.
Conley RR
J Clin Psychiatry; 2001; 62 Suppl 9():23-6; discussion 27-8. PubMed ID: 11379827
[TBL] [Abstract][Full Text] [Related]
31. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
[TBL] [Abstract][Full Text] [Related]
32. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
Nasrallah HA; Tandon R
J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
[TBL] [Abstract][Full Text] [Related]
33. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
34. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
Chéreau I; Gorwood P; Mouchabac S
Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
[No Abstract] [Full Text] [Related]
35. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.
van Berckel BN; Hijman R; van der Linden JA; Westenberg HG; van Ree JM; Kahn RS
Biol Psychiatry; 1996 Dec; 40(12):1298-300. PubMed ID: 8959296
[No Abstract] [Full Text] [Related]
36. Heterogeneity of treatment effects in schizophrenia.
Stroup TS
Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
[TBL] [Abstract][Full Text] [Related]
37. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Kulkarni AS
Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
[No Abstract] [Full Text] [Related]
38. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
Dassa D; Lacambre M; Vacheron MN
Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
[No Abstract] [Full Text] [Related]
39. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
40. The diagnosis and treatment of children and adolescents with schizophrenia. "My mind is playing tricks on me".
Kumra S
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):183-99, x. PubMed ID: 10674196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]